OPTI Stock Overview
OptiBiotix Health Plc, a life sciences company, engages in the research and development of microbiome modulators primarily in the United Kingdom.
OptiBiotix Health Plc Competitors
Price History & Performance
|Historical stock prices|
|Current Share Price||UK£0.15|
|52 Week High||UK£0.48|
|52 Week Low||UK£0.15|
|1 Month Change||-18.67%|
|3 Month Change||-8.96%|
|1 Year Change||-63.25%|
|3 Year Change||-67.20%|
|5 Year Change||-76.89%|
|Change since IPO||69.44%|
Recent News & Updates
|OPTI||GB Biotechs||GB Market|
Return vs Industry: OPTI underperformed the UK Biotechs industry which returned -35.1% over the past year.
Return vs Market: OPTI underperformed the UK Market which returned -8.8% over the past year.
|OPTI Average Weekly Movement||8.4%|
|Biotechs Industry Average Movement||7.6%|
|Market Average Movement||5.8%|
|10% most volatile stocks in GB Market||11.0%|
|10% least volatile stocks in GB Market||2.9%|
Stable Share Price: OPTI is more volatile than 75% of UK stocks over the past 3 months, typically moving +/- 8% a week.
Volatility Over Time: OPTI's weekly volatility (8%) has been stable over the past year, but is still higher than 75% of UK stocks.
About the Company
OptiBiotix Health Plc, a life sciences company, engages in the research and development of microbiome modulators primarily in the United Kingdom. The company identifies and develops microbial strains, compounds, and formulations for use in food ingredients, supplements, and active compounds that impacts human physiology deriving potential health benefits. Its products include Slimbiome, a natural ingredient, which offers a healthy and hunger-free weight management system; SlimBiome Medical, a natural supplement for weight management; CholBiome, a food supplement for maintaining healthy levels of cholesterol; Lactobacillus plantarum LPLDL, a probiotic that aids elements of cardiovascular and wellbeing; LPGOS, a galactooligosaccharid that is used in food products and applications, which helps in reducing cardiovascular risk factors and enhancing health; WellBiome, a functional fibre and mineral blend that supports health & wellbeing by promoting the diversity of the gut microbiome; and Sweetbiotix, a sweetener for use in food and beverages.
OptiBiotix Health Plc Fundamentals Summary
|OPTI fundamental statistics|
Is OPTI overvalued?See Fair Value and valuation analysis
Earnings & Revenue
|OPTI income statement (TTM)|
|Cost of Revenue||UK£544.47k|
Last Reported Earnings
Jun 30, 2022
Next Earnings Date
|Earnings per share (EPS)||0.065|
|Net Profit Margin||470.44%|
How did OPTI perform over the long term?See historical performance and comparison